Pat Beyer Power - 06 Jun 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: Director
Signature: /s/Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 06 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 08 Jun 2023, 18:45:53 UTC
Previous filing: 03 Mar 2023
Next filing: 20 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise	$0	+16,648	+1725%	$0.000000	17,613	06 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Options Exercise	$0	-16,648	-100%	$0.000000^*	0	06 Jun 2023	Class A Common Stock	16,648		Direct	F1, F2
transaction	BVS	Restricted Stock Units	Award	$0	+30,400		$0.000000	30,400	07 Jun 2023	Class A Common Stock	30,400		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2	The RSUs vested on June 6, 2023.
F3	The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.